Documentos relacionados

1. Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial.
2. Synthesis, structure-activity relationship and biological evaluation of indole derivatives as anti-Candida albicans agents.
3. Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats.
4. Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates.
5. Distribution of fungemia agents in five years and antifungal resistance.
6. Design, Synthesis, and Biological Evaluation of <i>N</i>'-Phenylhydrazides as Potential Antifungal Agents.
7. Persephacin Is a Broad-Spectrum Antifungal Aureobasidin Metabolite That Overcomes Intrinsic Resistance in <i>Aspergillus fumigatus</i>.
8. Pharmacokinetics of fluconazole after oral administration to healthy beagle dogs.
9. Synergy In Vitro of Nikkomycin Z with Azole Against the Invasive Form of Candida albicans.
10. [Mechanism of human airway epithelial cell injury induced by <i>Candida albicans</i> infection].